Global IVD and POCT Production, Demand and Key Producers, 2022-2028
This report studies the global IVD and POCT demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for IVD and POCT, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of IVD and POCT that contribute to its increasing demand across many markets.
The global IVD and POCT market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global IVD and POCT total market, 2017-2028, (USD Million)
Global IVD and POCT total market by region & country, CAGR, 2017-2028, (USD Million)
U.S. VS China: IVD and POCT total market, key domestic companies and share, (USD Million)
Global IVD and POCT revenue by player and market share 2017-2022, (USD Million)
Global IVD and POCT total market by Type, CAGR, 2017-2028, (USD Million)
Global IVD and POCT total market by Application, CAGR, 2017-2028, (USD Million)
This reports profiles major players in the global IVD and POCT market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Abbott, Johnson & Johnson, Siemens Healthcare, Danaher, Ascensia, Bio-Rad Laboratories, BioMerieux and ARKRAY, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World IVD and POCT market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global IVD and POCT Market, By Region:
1. How big is the global IVD and POCT market?
2. What is the demand of the global IVD and POCT market?
3. What is the year over year growth of the global IVD and POCT market?
4. What is the total value of the global IVD and POCT market?
5. Who are the major players in the global IVD and POCT market?
6. What are the growth factors driving the market demand?
This report is a detailed and comprehensive analysis of the world market for IVD and POCT, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of IVD and POCT that contribute to its increasing demand across many markets.
The global IVD and POCT market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global IVD and POCT total market, 2017-2028, (USD Million)
Global IVD and POCT total market by region & country, CAGR, 2017-2028, (USD Million)
U.S. VS China: IVD and POCT total market, key domestic companies and share, (USD Million)
Global IVD and POCT revenue by player and market share 2017-2022, (USD Million)
Global IVD and POCT total market by Type, CAGR, 2017-2028, (USD Million)
Global IVD and POCT total market by Application, CAGR, 2017-2028, (USD Million)
This reports profiles major players in the global IVD and POCT market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Abbott, Johnson & Johnson, Siemens Healthcare, Danaher, Ascensia, Bio-Rad Laboratories, BioMerieux and ARKRAY, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World IVD and POCT market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global IVD and POCT Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- POCT
- IVD
- Clinics
- Hospitals
- Laboratory
- Others
- Roche
- Abbott
- Johnson & Johnson
- Siemens Healthcare
- Danaher
- Ascensia
- Bio-Rad Laboratories
- BioMerieux
- ARKRAY
- Nova Biomedical
- Trividia Health
- Quidel
- Accriva
- OraSure Technologies
- Helena Laboratories
- A. Menarini Diagnostics
- Abaxis (Zoetis)
- Ortho Clinical Diagnostics
- Phamatech
- Chembio Diagnostics
- Trinity Biotech
- ELITech Group
- Response Biomedical
- Princeton BioMeditech
- Alfa Wassermann
1. How big is the global IVD and POCT market?
2. What is the demand of the global IVD and POCT market?
3. What is the year over year growth of the global IVD and POCT market?
4. What is the total value of the global IVD and POCT market?
5. Who are the major players in the global IVD and POCT market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 IVD and POCT Introduction
1.2 World IVD and POCT Market Size & Forecast (2017 & 2021 & 2028)
1.3 World IVD and POCT Total Market by Region
1.3.1 World IVD and POCT Market Size by Region (2017-2028)
1.3.2 United States IVD and POCT Market Size (2017-2028)
1.3.3 China IVD and POCT Market Size (2017-2028)
1.3.4 Europe IVD and POCT Market Size (2017-2028)
1.3.5 Japan IVD and POCT Market Size (2017-2028)
1.3.6 South Korea IVD and POCT Market Size (2017-2028)
1.3.7 ASEAN IVD and POCT Market Size (2017-2028)
1.3.8 India IVD and POCT Market Size (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 IVD and POCT Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 IVD and POCT Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 WORLD IVD AND POCT COMPANIES COMPETITIVE ANALYSIS
2.1 World IVD and POCT Revenue by Player (2017-2022)
2.2 Industry Rank and Concentration Rate (CR)
2.2.1 Global IVD and POCT Industry Rank of Major Players
2.2.2 Global Concentration Ratios (CR4) for IVD and POCT in 2021
2.2.3 Global Concentration Ratios (CR8) for IVD and POCT in 2021
2.3 IVD and POCT Company Evaluation Quadrant
2.4 IVD and POCT Market: Overall Company Footprint Analysis
2.4.1 IVD and POCT Market: Region Footprint
2.4.2 IVD and POCT Market: Company Product Type Footprint
2.4.3 IVD and POCT Market: Company Product Application Footprint
2.5 Competitive Environment
2.5.1 Historical Structure of the Industry
2.5.2 Barriers of Market Entry
2.5.3 Factors of Competition
2.6 Mergers, Acquisitions Activity
3 UNITED STATES VS CHINA VS REST OF THE WORLD
3.1 United States VS China: IVD and POCT Market Comparison
3.1.1 United States VS China: IVD and POCT Market Size Comparison (2017 & 2021 & 2028)
3.1.2 United States VS China: IVD and POCT Market Size Market Share Comparison (2017 & 2021 & 2028)
3.2 United States IVD and POCT Major Players and Market Share, 2017-2022
3.2.1 Major Players of IVD and POCT in United States, Headquarters (States, Country)
3.2.2 United States IVD and POCT Revenue by Domestic Player, (2017-2022)
3.3 China IVD and POCT Major Players and Market Share, 2017-2022
3.3.1 Major Players of IVD and POCT in China, Headquarters (Province, Country)
3.3.2 China IVD and POCT Revenue by Domestic Player, (2017-2022)
3.4 Rest of World IVD and POCT Major Players and Market Share, 2017-2022
3.4.1 Major Players of IVD and POCT in Rest of World, Headquarters (State, Country)
3.4.2 Rest of World IVD and POCT Revenue by Domestic Player, (2017-2022)
4 MARKET ANALYSIS BY TYPE
4.1 World IVD and POCT Market Size Overview by Type: 2017 VS 2021 VS 2028
4.2 Segment Introduction by Type
4.2.1 POCT
4.2.2 IVD
4.3 Market Segment by Type
4.3.1 World IVD and POCT Market Size by Type (2017-2022)
4.3.2 World IVD and POCT Market Size by Type (2023-2028)
4.3.3 World IVD and POCT Market Size Market Share by Type (2017-2028)
5 MARKET ANALYSIS BY APPLICATION
5.1 World IVD and POCT Market Size Overview by Application: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Application
5.2.1 Clinics
5.2.2 Hospitals
5.2.3 Laboratory
5.2.4 Others
5.2.5 Others
5.3 Market Segment by Application
5.3.1 World IVD and POCT Market Size by Application (2017-2022)
5.3.2 World IVD and POCT Market Size by Application (2023-2028)
5.3.3 World IVD and POCT Market Size by Application (2017-2028)
6 COMPANY PROFILES
6.1 Roche
6.1.1 Roche Details
6.1.2 Roche Major Business
6.1.3 Roche IVD and POCT Product and Services
6.1.4 Roche IVD and POCT Revenue, Gross Margin and Market Share (2017-2022)
6.1.5 Roche Recent Developments/Updates
6.1.6 Roche Competitive Strengths & Weaknesses
6.2 Abbott
6.2.1 Abbott Details
6.2.2 Abbott Major Business
6.2.3 Abbott IVD and POCT Product and Services
6.2.4 Abbott IVD and POCT Revenue, Gross Margin and Market Share (2017-2022)
6.2.5 Abbott Recent Developments/Updates
6.2.6 Abbott Competitive Strengths & Weaknesses
6.3 Johnson & Johnson
6.3.1 Johnson & Johnson Details
6.3.2 Johnson & Johnson Major Business
6.3.3 Johnson & Johnson IVD and POCT Product and Services
6.3.4 Johnson & Johnson IVD and POCT Revenue, Gross Margin and Market Share (2017-2022)
6.3.5 Johnson & Johnson Recent Developments/Updates
6.3.6 Johnson & Johnson Competitive Strengths & Weaknesses
6.4 Siemens Healthcare
6.4.1 Siemens Healthcare Details
6.4.2 Siemens Healthcare Major Business
6.4.3 Siemens Healthcare IVD and POCT Product and Services
6.4.4 Siemens Healthcare IVD and POCT Revenue, Gross Margin and Market Share (2017-2022)
6.4.5 Siemens Healthcare Recent Developments/Updates
6.4.6 Siemens Healthcare Competitive Strengths & Weaknesses
6.5 Danaher
6.5.1 Danaher Details
6.5.2 Danaher Major Business
6.5.3 Danaher IVD and POCT Product and Services
6.5.4 Danaher IVD and POCT Revenue, Gross Margin and Market Share (2017-2022)
6.5.5 Danaher Recent Developments/Updates
6.5.6 Danaher Competitive Strengths & Weaknesses
6.6 Ascensia
6.6.1 Ascensia Details
6.6.2 Ascensia Major Business
6.6.3 Ascensia IVD and POCT Product and Services
6.6.4 Ascensia IVD and POCT Revenue, Gross Margin and Market Share (2017-2022)
6.6.5 Ascensia Recent Developments/Updates
6.6.6 Ascensia Competitive Strengths & Weaknesses
6.7 Bio-Rad Laboratories
6.7.1 Bio-Rad Laboratories Details
6.7.2 Bio-Rad Laboratories Major Business
6.7.3 Bio-Rad Laboratories IVD and POCT Product and Services
6.7.4 Bio-Rad Laboratories IVD and POCT Revenue, Gross Margin and Market Share (2017-2022)
6.7.5 Bio-Rad Laboratories Recent Developments/Updates
6.7.6 Bio-Rad Laboratories Competitive Strengths & Weaknesses
6.8 BioMerieux
6.8.1 BioMerieux Details
6.8.2 BioMerieux Major Business
6.8.3 BioMerieux IVD and POCT Product and Services
6.8.4 BioMerieux IVD and POCT Revenue, Gross Margin and Market Share (2017-2022)
6.8.5 BioMerieux Recent Developments/Updates
6.8.6 BioMerieux Competitive Strengths & Weaknesses
6.9 ARKRAY
6.9.1 ARKRAY Details
6.9.2 ARKRAY Major Business
6.9.3 ARKRAY IVD and POCT Product and Services
6.9.4 ARKRAY IVD and POCT Revenue, Gross Margin and Market Share (2017-2022)
6.9.5 ARKRAY Recent Developments/Updates
6.9.6 ARKRAY Competitive Strengths & Weaknesses
6.10 Nova Biomedical
6.10.1 Nova Biomedical Details
6.10.2 Nova Biomedical Major Business
6.10.3 Nova Biomedical IVD and POCT Product and Services
6.10.4 Nova Biomedical IVD and POCT Revenue, Gross Margin and Market Share (2017-2022)
6.10.5 Nova Biomedical Recent Developments/Updates
6.10.6 Nova Biomedical Competitive Strengths & Weaknesses
6.11 Trividia Health
6.11.1 Trividia Health Details
6.11.2 Trividia Health Major Business
6.11.3 Trividia Health IVD and POCT Product and Services
6.11.4 Trividia Health IVD and POCT Revenue, Gross Margin and Market Share (2017-2022)
6.11.5 Trividia Health Recent Developments/Updates
6.11.6 Trividia Health Competitive Strengths & Weaknesses
6.12 Quidel
6.12.1 Quidel Details
6.12.2 Quidel Major Business
6.12.3 Quidel IVD and POCT Product and Services
6.12.4 Quidel IVD and POCT Revenue, Gross Margin and Market Share (2017-2022)
6.12.5 Quidel Recent Developments/Updates
6.12.6 Quidel Competitive Strengths & Weaknesses
6.13 Accriva
6.13.1 Accriva Details
6.13.2 Accriva Major Business
6.13.3 Accriva IVD and POCT Product and Services
6.13.4 Accriva IVD and POCT Revenue, Gross Margin and Market Share (2017-2022)
6.13.5 Accriva Recent Developments/Updates
6.13.6 Accriva Competitive Strengths & Weaknesses
6.14 OraSure Technologies
6.14.1 OraSure Technologies Details
6.14.2 OraSure Technologies Major Business
6.14.3 OraSure Technologies IVD and POCT Product and Services
6.14.4 OraSure Technologies IVD and POCT Revenue, Gross Margin and Market Share (2017-2022)
6.14.5 OraSure Technologies Recent Developments/Updates
6.14.6 OraSure Technologies Competitive Strengths & Weaknesses
6.15 Helena Laboratories
6.15.1 Helena Laboratories Details
6.15.2 Helena Laboratories Major Business
6.15.3 Helena Laboratories IVD and POCT Product and Services
6.15.4 Helena Laboratories IVD and POCT Revenue, Gross Margin and Market Share (2017-2022)
6.15.5 Helena Laboratories Recent Developments/Updates
6.15.6 Helena Laboratories Competitive Strengths & Weaknesses
6.16 A. Menarini Diagnostics
6.16.1 A. Menarini Diagnostics Details
6.16.2 A. Menarini Diagnostics Major Business
6.16.3 A. Menarini Diagnostics IVD and POCT Product and Services
6.16.4 A. Menarini Diagnostics IVD and POCT Revenue, Gross Margin and Market Share (2017-2022)
6.16.5 A. Menarini Diagnostics Recent Developments/Updates
6.16.6 A. Menarini Diagnostics Competitive Strengths & Weaknesses
6.17 Abaxis (Zoetis)
6.17.1 Abaxis (Zoetis) Details
6.17.2 Abaxis (Zoetis) Major Business
6.17.3 Abaxis (Zoetis) IVD and POCT Product and Services
6.17.4 Abaxis (Zoetis) IVD and POCT Revenue, Gross Margin and Market Share (2017-2022)
6.17.5 Abaxis (Zoetis) Recent Developments/Updates
6.17.6 Abaxis (Zoetis) Competitive Strengths & Weaknesses
6.18 Ortho Clinical Diagnostics
6.18.1 Ortho Clinical Diagnostics Details
6.18.2 Ortho Clinical Diagnostics Major Business
6.18.3 Ortho Clinical Diagnostics IVD and POCT Product and Services
6.18.4 Ortho Clinical Diagnostics IVD and POCT Revenue, Gross Margin and Market Share (2017-2022)
6.18.5 Ortho Clinical Diagnostics Recent Developments/Updates
6.18.6 Ortho Clinical Diagnostics Competitive Strengths & Weaknesses
6.19 Phamatech
6.19.1 Phamatech Details
6.19.2 Phamatech Major Business
6.19.3 Phamatech IVD and POCT Product and Services
6.19.4 Phamatech IVD and POCT Revenue, Gross Margin and Market Share (2017-2022)
6.19.5 Phamatech Recent Developments/Updates
6.19.6 Phamatech Competitive Strengths & Weaknesses
6.20 Chembio Diagnostics
6.20.1 Chembio Diagnostics Details
6.20.2 Chembio Diagnostics Major Business
6.20.3 Chembio Diagnostics IVD and POCT Product and Services
6.20.4 Chembio Diagnostics IVD and POCT Revenue, Gross Margin and Market Share (2017-2022)
6.20.5 Chembio Diagnostics Recent Developments/Updates
6.20.6 Chembio Diagnostics Competitive Strengths & Weaknesses
6.21 Trinity Biotech
6.21.1 Trinity Biotech Details
6.21.2 Trinity Biotech Major Business
6.21.3 Trinity Biotech IVD and POCT Product and Services
6.21.4 Trinity Biotech IVD and POCT Revenue, Gross Margin and Market Share (2017-2022)
6.21.5 Trinity Biotech Recent Developments/Updates
6.21.6 Trinity Biotech Competitive Strengths & Weaknesses
6.22 ELITech Group
6.22.1 ELITech Group Details
6.22.2 ELITech Group Major Business
6.22.3 ELITech Group IVD and POCT Product and Services
6.22.4 ELITech Group IVD and POCT Revenue, Gross Margin and Market Share (2017-2022)
6.22.5 ELITech Group Recent Developments/Updates
6.22.6 ELITech Group Competitive Strengths & Weaknesses
6.23 Response Biomedical
6.23.1 Response Biomedical Details
6.23.2 Response Biomedical Major Business
6.23.3 Response Biomedical IVD and POCT Product and Services
6.23.4 Response Biomedical IVD and POCT Revenue, Gross Margin and Market Share (2017-2022)
6.23.5 Response Biomedical Recent Developments/Updates
6.23.6 Response Biomedical Competitive Strengths & Weaknesses
6.24 Princeton BioMeditech
6.24.1 Princeton BioMeditech Details
6.24.2 Princeton BioMeditech Major Business
6.24.3 Princeton BioMeditech IVD and POCT Product and Services
6.24.4 Princeton BioMeditech IVD and POCT Revenue, Gross Margin and Market Share (2017-2022)
6.24.5 Princeton BioMeditech Recent Developments/Updates
6.24.6 Princeton BioMeditech Competitive Strengths & Weaknesses
6.25 Alfa Wassermann
6.25.1 Alfa Wassermann Details
6.25.2 Alfa Wassermann Major Business
6.25.3 Alfa Wassermann IVD and POCT Product and Services
6.25.4 Alfa Wassermann IVD and POCT Revenue, Gross Margin and Market Share (2017-2022)
6.25.5 Alfa Wassermann Recent Developments/Updates
6.25.6 Alfa Wassermann Competitive Strengths & Weaknesses
7 RAW MATERIAL AND INDUSTRY CHAIN
7.1 Raw Material of IVD and POCT and Key Manufacturers
7.2 IVD and POCT Manufacturing Costs
7.3 IVD and POCT Production Process
7.4 IVD and POCT Industrial Chain
8 DISTRIBUTION CHANNEL ANALYSIS
8.1 Distribution Channel Breakdown for IVD and POCT Shipments (%): 2017-2028
8.1.1 Direct Channel
8.1.2 Indirect Channel
8.2 IVD and POCT Typical Distributors
8.3 IVD and POCT Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 IVD and POCT Introduction
1.2 World IVD and POCT Market Size & Forecast (2017 & 2021 & 2028)
1.3 World IVD and POCT Total Market by Region
1.3.1 World IVD and POCT Market Size by Region (2017-2028)
1.3.2 United States IVD and POCT Market Size (2017-2028)
1.3.3 China IVD and POCT Market Size (2017-2028)
1.3.4 Europe IVD and POCT Market Size (2017-2028)
1.3.5 Japan IVD and POCT Market Size (2017-2028)
1.3.6 South Korea IVD and POCT Market Size (2017-2028)
1.3.7 ASEAN IVD and POCT Market Size (2017-2028)
1.3.8 India IVD and POCT Market Size (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 IVD and POCT Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 IVD and POCT Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 WORLD IVD AND POCT COMPANIES COMPETITIVE ANALYSIS
2.1 World IVD and POCT Revenue by Player (2017-2022)
2.2 Industry Rank and Concentration Rate (CR)
2.2.1 Global IVD and POCT Industry Rank of Major Players
2.2.2 Global Concentration Ratios (CR4) for IVD and POCT in 2021
2.2.3 Global Concentration Ratios (CR8) for IVD and POCT in 2021
2.3 IVD and POCT Company Evaluation Quadrant
2.4 IVD and POCT Market: Overall Company Footprint Analysis
2.4.1 IVD and POCT Market: Region Footprint
2.4.2 IVD and POCT Market: Company Product Type Footprint
2.4.3 IVD and POCT Market: Company Product Application Footprint
2.5 Competitive Environment
2.5.1 Historical Structure of the Industry
2.5.2 Barriers of Market Entry
2.5.3 Factors of Competition
2.6 Mergers, Acquisitions Activity
3 UNITED STATES VS CHINA VS REST OF THE WORLD
3.1 United States VS China: IVD and POCT Market Comparison
3.1.1 United States VS China: IVD and POCT Market Size Comparison (2017 & 2021 & 2028)
3.1.2 United States VS China: IVD and POCT Market Size Market Share Comparison (2017 & 2021 & 2028)
3.2 United States IVD and POCT Major Players and Market Share, 2017-2022
3.2.1 Major Players of IVD and POCT in United States, Headquarters (States, Country)
3.2.2 United States IVD and POCT Revenue by Domestic Player, (2017-2022)
3.3 China IVD and POCT Major Players and Market Share, 2017-2022
3.3.1 Major Players of IVD and POCT in China, Headquarters (Province, Country)
3.3.2 China IVD and POCT Revenue by Domestic Player, (2017-2022)
3.4 Rest of World IVD and POCT Major Players and Market Share, 2017-2022
3.4.1 Major Players of IVD and POCT in Rest of World, Headquarters (State, Country)
3.4.2 Rest of World IVD and POCT Revenue by Domestic Player, (2017-2022)
4 MARKET ANALYSIS BY TYPE
4.1 World IVD and POCT Market Size Overview by Type: 2017 VS 2021 VS 2028
4.2 Segment Introduction by Type
4.2.1 POCT
4.2.2 IVD
4.3 Market Segment by Type
4.3.1 World IVD and POCT Market Size by Type (2017-2022)
4.3.2 World IVD and POCT Market Size by Type (2023-2028)
4.3.3 World IVD and POCT Market Size Market Share by Type (2017-2028)
5 MARKET ANALYSIS BY APPLICATION
5.1 World IVD and POCT Market Size Overview by Application: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Application
5.2.1 Clinics
5.2.2 Hospitals
5.2.3 Laboratory
5.2.4 Others
5.2.5 Others
5.3 Market Segment by Application
5.3.1 World IVD and POCT Market Size by Application (2017-2022)
5.3.2 World IVD and POCT Market Size by Application (2023-2028)
5.3.3 World IVD and POCT Market Size by Application (2017-2028)
6 COMPANY PROFILES
6.1 Roche
6.1.1 Roche Details
6.1.2 Roche Major Business
6.1.3 Roche IVD and POCT Product and Services
6.1.4 Roche IVD and POCT Revenue, Gross Margin and Market Share (2017-2022)
6.1.5 Roche Recent Developments/Updates
6.1.6 Roche Competitive Strengths & Weaknesses
6.2 Abbott
6.2.1 Abbott Details
6.2.2 Abbott Major Business
6.2.3 Abbott IVD and POCT Product and Services
6.2.4 Abbott IVD and POCT Revenue, Gross Margin and Market Share (2017-2022)
6.2.5 Abbott Recent Developments/Updates
6.2.6 Abbott Competitive Strengths & Weaknesses
6.3 Johnson & Johnson
6.3.1 Johnson & Johnson Details
6.3.2 Johnson & Johnson Major Business
6.3.3 Johnson & Johnson IVD and POCT Product and Services
6.3.4 Johnson & Johnson IVD and POCT Revenue, Gross Margin and Market Share (2017-2022)
6.3.5 Johnson & Johnson Recent Developments/Updates
6.3.6 Johnson & Johnson Competitive Strengths & Weaknesses
6.4 Siemens Healthcare
6.4.1 Siemens Healthcare Details
6.4.2 Siemens Healthcare Major Business
6.4.3 Siemens Healthcare IVD and POCT Product and Services
6.4.4 Siemens Healthcare IVD and POCT Revenue, Gross Margin and Market Share (2017-2022)
6.4.5 Siemens Healthcare Recent Developments/Updates
6.4.6 Siemens Healthcare Competitive Strengths & Weaknesses
6.5 Danaher
6.5.1 Danaher Details
6.5.2 Danaher Major Business
6.5.3 Danaher IVD and POCT Product and Services
6.5.4 Danaher IVD and POCT Revenue, Gross Margin and Market Share (2017-2022)
6.5.5 Danaher Recent Developments/Updates
6.5.6 Danaher Competitive Strengths & Weaknesses
6.6 Ascensia
6.6.1 Ascensia Details
6.6.2 Ascensia Major Business
6.6.3 Ascensia IVD and POCT Product and Services
6.6.4 Ascensia IVD and POCT Revenue, Gross Margin and Market Share (2017-2022)
6.6.5 Ascensia Recent Developments/Updates
6.6.6 Ascensia Competitive Strengths & Weaknesses
6.7 Bio-Rad Laboratories
6.7.1 Bio-Rad Laboratories Details
6.7.2 Bio-Rad Laboratories Major Business
6.7.3 Bio-Rad Laboratories IVD and POCT Product and Services
6.7.4 Bio-Rad Laboratories IVD and POCT Revenue, Gross Margin and Market Share (2017-2022)
6.7.5 Bio-Rad Laboratories Recent Developments/Updates
6.7.6 Bio-Rad Laboratories Competitive Strengths & Weaknesses
6.8 BioMerieux
6.8.1 BioMerieux Details
6.8.2 BioMerieux Major Business
6.8.3 BioMerieux IVD and POCT Product and Services
6.8.4 BioMerieux IVD and POCT Revenue, Gross Margin and Market Share (2017-2022)
6.8.5 BioMerieux Recent Developments/Updates
6.8.6 BioMerieux Competitive Strengths & Weaknesses
6.9 ARKRAY
6.9.1 ARKRAY Details
6.9.2 ARKRAY Major Business
6.9.3 ARKRAY IVD and POCT Product and Services
6.9.4 ARKRAY IVD and POCT Revenue, Gross Margin and Market Share (2017-2022)
6.9.5 ARKRAY Recent Developments/Updates
6.9.6 ARKRAY Competitive Strengths & Weaknesses
6.10 Nova Biomedical
6.10.1 Nova Biomedical Details
6.10.2 Nova Biomedical Major Business
6.10.3 Nova Biomedical IVD and POCT Product and Services
6.10.4 Nova Biomedical IVD and POCT Revenue, Gross Margin and Market Share (2017-2022)
6.10.5 Nova Biomedical Recent Developments/Updates
6.10.6 Nova Biomedical Competitive Strengths & Weaknesses
6.11 Trividia Health
6.11.1 Trividia Health Details
6.11.2 Trividia Health Major Business
6.11.3 Trividia Health IVD and POCT Product and Services
6.11.4 Trividia Health IVD and POCT Revenue, Gross Margin and Market Share (2017-2022)
6.11.5 Trividia Health Recent Developments/Updates
6.11.6 Trividia Health Competitive Strengths & Weaknesses
6.12 Quidel
6.12.1 Quidel Details
6.12.2 Quidel Major Business
6.12.3 Quidel IVD and POCT Product and Services
6.12.4 Quidel IVD and POCT Revenue, Gross Margin and Market Share (2017-2022)
6.12.5 Quidel Recent Developments/Updates
6.12.6 Quidel Competitive Strengths & Weaknesses
6.13 Accriva
6.13.1 Accriva Details
6.13.2 Accriva Major Business
6.13.3 Accriva IVD and POCT Product and Services
6.13.4 Accriva IVD and POCT Revenue, Gross Margin and Market Share (2017-2022)
6.13.5 Accriva Recent Developments/Updates
6.13.6 Accriva Competitive Strengths & Weaknesses
6.14 OraSure Technologies
6.14.1 OraSure Technologies Details
6.14.2 OraSure Technologies Major Business
6.14.3 OraSure Technologies IVD and POCT Product and Services
6.14.4 OraSure Technologies IVD and POCT Revenue, Gross Margin and Market Share (2017-2022)
6.14.5 OraSure Technologies Recent Developments/Updates
6.14.6 OraSure Technologies Competitive Strengths & Weaknesses
6.15 Helena Laboratories
6.15.1 Helena Laboratories Details
6.15.2 Helena Laboratories Major Business
6.15.3 Helena Laboratories IVD and POCT Product and Services
6.15.4 Helena Laboratories IVD and POCT Revenue, Gross Margin and Market Share (2017-2022)
6.15.5 Helena Laboratories Recent Developments/Updates
6.15.6 Helena Laboratories Competitive Strengths & Weaknesses
6.16 A. Menarini Diagnostics
6.16.1 A. Menarini Diagnostics Details
6.16.2 A. Menarini Diagnostics Major Business
6.16.3 A. Menarini Diagnostics IVD and POCT Product and Services
6.16.4 A. Menarini Diagnostics IVD and POCT Revenue, Gross Margin and Market Share (2017-2022)
6.16.5 A. Menarini Diagnostics Recent Developments/Updates
6.16.6 A. Menarini Diagnostics Competitive Strengths & Weaknesses
6.17 Abaxis (Zoetis)
6.17.1 Abaxis (Zoetis) Details
6.17.2 Abaxis (Zoetis) Major Business
6.17.3 Abaxis (Zoetis) IVD and POCT Product and Services
6.17.4 Abaxis (Zoetis) IVD and POCT Revenue, Gross Margin and Market Share (2017-2022)
6.17.5 Abaxis (Zoetis) Recent Developments/Updates
6.17.6 Abaxis (Zoetis) Competitive Strengths & Weaknesses
6.18 Ortho Clinical Diagnostics
6.18.1 Ortho Clinical Diagnostics Details
6.18.2 Ortho Clinical Diagnostics Major Business
6.18.3 Ortho Clinical Diagnostics IVD and POCT Product and Services
6.18.4 Ortho Clinical Diagnostics IVD and POCT Revenue, Gross Margin and Market Share (2017-2022)
6.18.5 Ortho Clinical Diagnostics Recent Developments/Updates
6.18.6 Ortho Clinical Diagnostics Competitive Strengths & Weaknesses
6.19 Phamatech
6.19.1 Phamatech Details
6.19.2 Phamatech Major Business
6.19.3 Phamatech IVD and POCT Product and Services
6.19.4 Phamatech IVD and POCT Revenue, Gross Margin and Market Share (2017-2022)
6.19.5 Phamatech Recent Developments/Updates
6.19.6 Phamatech Competitive Strengths & Weaknesses
6.20 Chembio Diagnostics
6.20.1 Chembio Diagnostics Details
6.20.2 Chembio Diagnostics Major Business
6.20.3 Chembio Diagnostics IVD and POCT Product and Services
6.20.4 Chembio Diagnostics IVD and POCT Revenue, Gross Margin and Market Share (2017-2022)
6.20.5 Chembio Diagnostics Recent Developments/Updates
6.20.6 Chembio Diagnostics Competitive Strengths & Weaknesses
6.21 Trinity Biotech
6.21.1 Trinity Biotech Details
6.21.2 Trinity Biotech Major Business
6.21.3 Trinity Biotech IVD and POCT Product and Services
6.21.4 Trinity Biotech IVD and POCT Revenue, Gross Margin and Market Share (2017-2022)
6.21.5 Trinity Biotech Recent Developments/Updates
6.21.6 Trinity Biotech Competitive Strengths & Weaknesses
6.22 ELITech Group
6.22.1 ELITech Group Details
6.22.2 ELITech Group Major Business
6.22.3 ELITech Group IVD and POCT Product and Services
6.22.4 ELITech Group IVD and POCT Revenue, Gross Margin and Market Share (2017-2022)
6.22.5 ELITech Group Recent Developments/Updates
6.22.6 ELITech Group Competitive Strengths & Weaknesses
6.23 Response Biomedical
6.23.1 Response Biomedical Details
6.23.2 Response Biomedical Major Business
6.23.3 Response Biomedical IVD and POCT Product and Services
6.23.4 Response Biomedical IVD and POCT Revenue, Gross Margin and Market Share (2017-2022)
6.23.5 Response Biomedical Recent Developments/Updates
6.23.6 Response Biomedical Competitive Strengths & Weaknesses
6.24 Princeton BioMeditech
6.24.1 Princeton BioMeditech Details
6.24.2 Princeton BioMeditech Major Business
6.24.3 Princeton BioMeditech IVD and POCT Product and Services
6.24.4 Princeton BioMeditech IVD and POCT Revenue, Gross Margin and Market Share (2017-2022)
6.24.5 Princeton BioMeditech Recent Developments/Updates
6.24.6 Princeton BioMeditech Competitive Strengths & Weaknesses
6.25 Alfa Wassermann
6.25.1 Alfa Wassermann Details
6.25.2 Alfa Wassermann Major Business
6.25.3 Alfa Wassermann IVD and POCT Product and Services
6.25.4 Alfa Wassermann IVD and POCT Revenue, Gross Margin and Market Share (2017-2022)
6.25.5 Alfa Wassermann Recent Developments/Updates
6.25.6 Alfa Wassermann Competitive Strengths & Weaknesses
7 RAW MATERIAL AND INDUSTRY CHAIN
7.1 Raw Material of IVD and POCT and Key Manufacturers
7.2 IVD and POCT Manufacturing Costs
7.3 IVD and POCT Production Process
7.4 IVD and POCT Industrial Chain
8 DISTRIBUTION CHANNEL ANALYSIS
8.1 Distribution Channel Breakdown for IVD and POCT Shipments (%): 2017-2028
8.1.1 Direct Channel
8.1.2 Indirect Channel
8.2 IVD and POCT Typical Distributors
8.3 IVD and POCT Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World IVD and POCT Market Size by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World IVD and POCT Market Size by Region (2017-2022) & (USD Million)
Table 3. World IVD and POCT Market Size by Region (2023-2028) & (USD Million)
Table 4. World IVD and POCT Market Size Market Share by Region (2017-2022)
Table 5. World IVD and POCT Market Size Market Share by Region (2023-2028)
Table 6. Major Market Trends
Table 7. World IVD and POCT Revenue by Player (2017-2022) & (USD Million)
Table 8. Revenue Market Share of Key IVD and POCT Players in 2021
Table 9. World IVD and POCT Industry Rank of Major Player, Based on Revenue in 2021
Table 10. Global IVD and POCT Company Evaluation Quadrant
Table 11. Head Office of Key IVD and POCT Player
Table 12. IVD and POCT Market: Company Product Type Footprint
Table 13. IVD and POCT Market: Company Product Application Footprint
Table 14. IVD and POCT Mergers & Acquisitions Activity
Table 15. United States VS China IVD and POCT Market Size Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 16. Major Player of IVD and POCT in United States, Headquarters (States, Country)
Table 17. United States IVD and POCT Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 18. United States IVD and POCT Revenue Market Share by Domestic Player, (2017-2022)
Table 19. Major Player of IVD and POCT in China, Company Headquarters (Province, Country)
Table 20. China IVD and POCT Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 21. China IVD and POCT Revenue Market Share by Domestic Player, (2017-2022)
Table 22. Major Player of IVD and POCT in Rest of World, Company Headquarters (State, Country)
Table 23. Rest of World IVD and POCT Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 24. Rest of World IVD and POCT Revenue Market Share by Domestic Player, (2017-2022)
Table 25. World IVD and POCT Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 26. World IVD and POCT Revenue by Type (2017-2022) & (USD Million)
Table 27. World IVD and POCT Revenue by Type (2023-2028) & (USD Million)
Table 28. World IVD and POCT Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 29. World IVD and POCT Revenue by Application (2017-2022) & (USD Million)
Table 30. World IVD and POCT Revenue by Application (2023-2028) & (USD Million)
Table 31. Roche Basic Information, Area Served and Competitors
Table 32. Roche Major Business
Table 33. Roche IVD and POCT Product and Services
Table 34. Roche IVD and POCT Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 35. Roche Recent Developments/Updates
Table 36. Roche Competitive Strengths & Weaknesses
Table 37. Abbott Basic Information, Area Served and Competitors
Table 38. Abbott Major Business
Table 39. Abbott IVD and POCT Product and Services
Table 40. Abbott IVD and POCT Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 41. Abbott Recent Developments/Updates
Table 42. Abbott Competitive Strengths & Weaknesses
Table 43. Johnson & Johnson Basic Information, Area Served and Competitors
Table 44. Johnson & Johnson Major Business
Table 45. Johnson & Johnson IVD and POCT Product and Services
Table 46. Johnson & Johnson IVD and POCT Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 47. Johnson & Johnson Recent Developments/Updates
Table 48. Johnson & Johnson Competitive Strengths & Weaknesses
Table 49. Siemens Healthcare Basic Information, Area Served and Competitors
Table 50. Siemens Healthcare Major Business
Table 51. Siemens Healthcare IVD and POCT Product and Services
Table 52. Siemens Healthcare IVD and POCT Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 53. Siemens Healthcare Recent Developments/Updates
Table 54. Siemens Healthcare Competitive Strengths & Weaknesses
Table 55. Danaher Basic Information, Area Served and Competitors
Table 56. Danaher Major Business
Table 57. Danaher IVD and POCT Product and Services
Table 58. Danaher IVD and POCT Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 59. Danaher Recent Developments/Updates
Table 60. Danaher Competitive Strengths & Weaknesses
Table 61. Ascensia Basic Information, Area Served and Competitors
Table 62. Ascensia Major Business
Table 63. Ascensia IVD and POCT Product and Services
Table 64. Ascensia IVD and POCT Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 65. Ascensia Recent Developments/Updates
Table 66. Ascensia Competitive Strengths & Weaknesses
Table 67. Bio-Rad Laboratories Basic Information, Area Served and Competitors
Table 68. Bio-Rad Laboratories Major Business
Table 69. Bio-Rad Laboratories IVD and POCT Product and Services
Table 70. Bio-Rad Laboratories IVD and POCT Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 71. Bio-Rad Laboratories Recent Developments/Updates
Table 72. Bio-Rad Laboratories Competitive Strengths & Weaknesses
Table 73. BioMerieux Basic Information, Area Served and Competitors
Table 74. BioMerieux Major Business
Table 75. BioMerieux IVD and POCT Product and Services
Table 76. BioMerieux IVD and POCT Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 77. BioMerieux Recent Developments/Updates
Table 78. BioMerieux Competitive Strengths & Weaknesses
Table 79. ARKRAY Basic Information, Area Served and Competitors
Table 80. ARKRAY Major Business
Table 81. ARKRAY IVD and POCT Product and Services
Table 82. ARKRAY IVD and POCT Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 83. ARKRAY Recent Developments/Updates
Table 84. ARKRAY Competitive Strengths & Weaknesses
Table 85. Nova Biomedical Basic Information, Area Served and Competitors
Table 86. Nova Biomedical Major Business
Table 87. Nova Biomedical IVD and POCT Product and Services
Table 88. Nova Biomedical IVD and POCT Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 89. Nova Biomedical Recent Developments/Updates
Table 90. Nova Biomedical Competitive Strengths & Weaknesses
Table 91. Trividia Health Basic Information, Area Served and Competitors
Table 92. Trividia Health Major Business
Table 93. Trividia Health IVD and POCT Product and Services
Table 94. Trividia Health IVD and POCT Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 95. Trividia Health Recent Developments/Updates
Table 96. Trividia Health Competitive Strengths & Weaknesses
Table 97. Quidel Basic Information, Area Served and Competitors
Table 98. Quidel Major Business
Table 99. Quidel IVD and POCT Product and Services
Table 100. Quidel IVD and POCT Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 101. Quidel Recent Developments/Updates
Table 102. Quidel Competitive Strengths & Weaknesses
Table 103. Accriva Basic Information, Area Served and Competitors
Table 104. Accriva Major Business
Table 105. Accriva IVD and POCT Product and Services
Table 106. Accriva IVD and POCT Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 107. Accriva Recent Developments/Updates
Table 108. Accriva Competitive Strengths & Weaknesses
Table 109. OraSure Technologies Basic Information, Area Served and Competitors
Table 110. OraSure Technologies Major Business
Table 111. OraSure Technologies IVD and POCT Product and Services
Table 112. OraSure Technologies IVD and POCT Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 113. OraSure Technologies Recent Developments/Updates
Table 114. OraSure Technologies Competitive Strengths & Weaknesses
Table 115. Helena Laboratories Basic Information, Area Served and Competitors
Table 116. Helena Laboratories Major Business
Table 117. Helena Laboratories IVD and POCT Product and Services
Table 118. Helena Laboratories IVD and POCT Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 119. Helena Laboratories Recent Developments/Updates
Table 120. Helena Laboratories Competitive Strengths & Weaknesses
Table 121. A. Menarini Diagnostics Basic Information, Area Served and Competitors
Table 122. A. Menarini Diagnostics Major Business
Table 123. A. Menarini Diagnostics IVD and POCT Product and Services
Table 124. A. Menarini Diagnostics IVD and POCT Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 125. A. Menarini Diagnostics Recent Developments/Updates
Table 126. A. Menarini Diagnostics Competitive Strengths & Weaknesses
Table 127. Abaxis (Zoetis) Basic Information, Area Served and Competitors
Table 128. Abaxis (Zoetis) Major Business
Table 129. Abaxis (Zoetis) IVD and POCT Product and Services
Table 130. Abaxis (Zoetis) IVD and POCT Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 131. Abaxis (Zoetis) Recent Developments/Updates
Table 132. Abaxis (Zoetis) Competitive Strengths & Weaknesses
Table 133. Ortho Clinical Diagnostics Basic Information, Area Served and Competitors
Table 134. Ortho Clinical Diagnostics Major Business
Table 135. Ortho Clinical Diagnostics IVD and POCT Product and Services
Table 136. Ortho Clinical Diagnostics IVD and POCT Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 137. Ortho Clinical Diagnostics Recent Developments/Updates
Table 138. Ortho Clinical Diagnostics Competitive Strengths & Weaknesses
Table 139. Phamatech Basic Information, Area Served and Competitors
Table 140. Phamatech Major Business
Table 141. Phamatech IVD and POCT Product and Services
Table 142. Phamatech IVD and POCT Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 143. Phamatech Recent Developments/Updates
Table 144. Phamatech Competitive Strengths & Weaknesses
Table 145. Chembio Diagnostics Basic Information, Area Served and Competitors
Table 146. Chembio Diagnostics Major Business
Table 147. Chembio Diagnostics IVD and POCT Product and Services
Table 148. Chembio Diagnostics IVD and POCT Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 149. Chembio Diagnostics Recent Developments/Updates
Table 150. Chembio Diagnostics Competitive Strengths & Weaknesses
Table 151. Trinity Biotech Basic Information, Area Served and Competitors
Table 152. Trinity Biotech Major Business
Table 153. Trinity Biotech IVD and POCT Product and Services
Table 154. Trinity Biotech IVD and POCT Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 155. Trinity Biotech Recent Developments/Updates
Table 156. Trinity Biotech Competitive Strengths & Weaknesses
Table 157. ELITech Group Basic Information, Area Served and Competitors
Table 158. ELITech Group Major Business
Table 159. ELITech Group IVD and POCT Product and Services
Table 160. ELITech Group IVD and POCT Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 161. ELITech Group Recent Developments/Updates
Table 162. ELITech Group Competitive Strengths & Weaknesses
Table 163. Response Biomedical Basic Information, Area Served and Competitors
Table 164. Response Biomedical Major Business
Table 165. Response Biomedical IVD and POCT Product and Services
Table 166. Response Biomedical IVD and POCT Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 167. Response Biomedical Recent Developments/Updates
Table 168. Response Biomedical Competitive Strengths & Weaknesses
Table 169. Princeton BioMeditech Basic Information, Area Served and Competitors
Table 170. Princeton BioMeditech Major Business
Table 171. Princeton BioMeditech IVD and POCT Product and Services
Table 172. Princeton BioMeditech IVD and POCT Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 173. Princeton BioMeditech Recent Developments/Updates
Table 174. Alfa Wassermann Basic Information, Area Served and Competitors
Table 175. Alfa Wassermann Major Business
Table 176. Alfa Wassermann IVD and POCT Product and Services
Table 177. Alfa Wassermann IVD and POCT Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 178. IVD and POCT Raw Material
Table 179. Key Manufacturers of IVD and POCT Raw Materials
Table 180. IVD and POCT Typical Distributors
Table 181. IVD and POCT Typical Customers
Table 1. World IVD and POCT Market Size by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World IVD and POCT Market Size by Region (2017-2022) & (USD Million)
Table 3. World IVD and POCT Market Size by Region (2023-2028) & (USD Million)
Table 4. World IVD and POCT Market Size Market Share by Region (2017-2022)
Table 5. World IVD and POCT Market Size Market Share by Region (2023-2028)
Table 6. Major Market Trends
Table 7. World IVD and POCT Revenue by Player (2017-2022) & (USD Million)
Table 8. Revenue Market Share of Key IVD and POCT Players in 2021
Table 9. World IVD and POCT Industry Rank of Major Player, Based on Revenue in 2021
Table 10. Global IVD and POCT Company Evaluation Quadrant
Table 11. Head Office of Key IVD and POCT Player
Table 12. IVD and POCT Market: Company Product Type Footprint
Table 13. IVD and POCT Market: Company Product Application Footprint
Table 14. IVD and POCT Mergers & Acquisitions Activity
Table 15. United States VS China IVD and POCT Market Size Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 16. Major Player of IVD and POCT in United States, Headquarters (States, Country)
Table 17. United States IVD and POCT Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 18. United States IVD and POCT Revenue Market Share by Domestic Player, (2017-2022)
Table 19. Major Player of IVD and POCT in China, Company Headquarters (Province, Country)
Table 20. China IVD and POCT Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 21. China IVD and POCT Revenue Market Share by Domestic Player, (2017-2022)
Table 22. Major Player of IVD and POCT in Rest of World, Company Headquarters (State, Country)
Table 23. Rest of World IVD and POCT Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 24. Rest of World IVD and POCT Revenue Market Share by Domestic Player, (2017-2022)
Table 25. World IVD and POCT Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 26. World IVD and POCT Revenue by Type (2017-2022) & (USD Million)
Table 27. World IVD and POCT Revenue by Type (2023-2028) & (USD Million)
Table 28. World IVD and POCT Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 29. World IVD and POCT Revenue by Application (2017-2022) & (USD Million)
Table 30. World IVD and POCT Revenue by Application (2023-2028) & (USD Million)
Table 31. Roche Basic Information, Area Served and Competitors
Table 32. Roche Major Business
Table 33. Roche IVD and POCT Product and Services
Table 34. Roche IVD and POCT Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 35. Roche Recent Developments/Updates
Table 36. Roche Competitive Strengths & Weaknesses
Table 37. Abbott Basic Information, Area Served and Competitors
Table 38. Abbott Major Business
Table 39. Abbott IVD and POCT Product and Services
Table 40. Abbott IVD and POCT Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 41. Abbott Recent Developments/Updates
Table 42. Abbott Competitive Strengths & Weaknesses
Table 43. Johnson & Johnson Basic Information, Area Served and Competitors
Table 44. Johnson & Johnson Major Business
Table 45. Johnson & Johnson IVD and POCT Product and Services
Table 46. Johnson & Johnson IVD and POCT Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 47. Johnson & Johnson Recent Developments/Updates
Table 48. Johnson & Johnson Competitive Strengths & Weaknesses
Table 49. Siemens Healthcare Basic Information, Area Served and Competitors
Table 50. Siemens Healthcare Major Business
Table 51. Siemens Healthcare IVD and POCT Product and Services
Table 52. Siemens Healthcare IVD and POCT Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 53. Siemens Healthcare Recent Developments/Updates
Table 54. Siemens Healthcare Competitive Strengths & Weaknesses
Table 55. Danaher Basic Information, Area Served and Competitors
Table 56. Danaher Major Business
Table 57. Danaher IVD and POCT Product and Services
Table 58. Danaher IVD and POCT Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 59. Danaher Recent Developments/Updates
Table 60. Danaher Competitive Strengths & Weaknesses
Table 61. Ascensia Basic Information, Area Served and Competitors
Table 62. Ascensia Major Business
Table 63. Ascensia IVD and POCT Product and Services
Table 64. Ascensia IVD and POCT Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 65. Ascensia Recent Developments/Updates
Table 66. Ascensia Competitive Strengths & Weaknesses
Table 67. Bio-Rad Laboratories Basic Information, Area Served and Competitors
Table 68. Bio-Rad Laboratories Major Business
Table 69. Bio-Rad Laboratories IVD and POCT Product and Services
Table 70. Bio-Rad Laboratories IVD and POCT Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 71. Bio-Rad Laboratories Recent Developments/Updates
Table 72. Bio-Rad Laboratories Competitive Strengths & Weaknesses
Table 73. BioMerieux Basic Information, Area Served and Competitors
Table 74. BioMerieux Major Business
Table 75. BioMerieux IVD and POCT Product and Services
Table 76. BioMerieux IVD and POCT Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 77. BioMerieux Recent Developments/Updates
Table 78. BioMerieux Competitive Strengths & Weaknesses
Table 79. ARKRAY Basic Information, Area Served and Competitors
Table 80. ARKRAY Major Business
Table 81. ARKRAY IVD and POCT Product and Services
Table 82. ARKRAY IVD and POCT Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 83. ARKRAY Recent Developments/Updates
Table 84. ARKRAY Competitive Strengths & Weaknesses
Table 85. Nova Biomedical Basic Information, Area Served and Competitors
Table 86. Nova Biomedical Major Business
Table 87. Nova Biomedical IVD and POCT Product and Services
Table 88. Nova Biomedical IVD and POCT Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 89. Nova Biomedical Recent Developments/Updates
Table 90. Nova Biomedical Competitive Strengths & Weaknesses
Table 91. Trividia Health Basic Information, Area Served and Competitors
Table 92. Trividia Health Major Business
Table 93. Trividia Health IVD and POCT Product and Services
Table 94. Trividia Health IVD and POCT Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 95. Trividia Health Recent Developments/Updates
Table 96. Trividia Health Competitive Strengths & Weaknesses
Table 97. Quidel Basic Information, Area Served and Competitors
Table 98. Quidel Major Business
Table 99. Quidel IVD and POCT Product and Services
Table 100. Quidel IVD and POCT Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 101. Quidel Recent Developments/Updates
Table 102. Quidel Competitive Strengths & Weaknesses
Table 103. Accriva Basic Information, Area Served and Competitors
Table 104. Accriva Major Business
Table 105. Accriva IVD and POCT Product and Services
Table 106. Accriva IVD and POCT Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 107. Accriva Recent Developments/Updates
Table 108. Accriva Competitive Strengths & Weaknesses
Table 109. OraSure Technologies Basic Information, Area Served and Competitors
Table 110. OraSure Technologies Major Business
Table 111. OraSure Technologies IVD and POCT Product and Services
Table 112. OraSure Technologies IVD and POCT Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 113. OraSure Technologies Recent Developments/Updates
Table 114. OraSure Technologies Competitive Strengths & Weaknesses
Table 115. Helena Laboratories Basic Information, Area Served and Competitors
Table 116. Helena Laboratories Major Business
Table 117. Helena Laboratories IVD and POCT Product and Services
Table 118. Helena Laboratories IVD and POCT Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 119. Helena Laboratories Recent Developments/Updates
Table 120. Helena Laboratories Competitive Strengths & Weaknesses
Table 121. A. Menarini Diagnostics Basic Information, Area Served and Competitors
Table 122. A. Menarini Diagnostics Major Business
Table 123. A. Menarini Diagnostics IVD and POCT Product and Services
Table 124. A. Menarini Diagnostics IVD and POCT Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 125. A. Menarini Diagnostics Recent Developments/Updates
Table 126. A. Menarini Diagnostics Competitive Strengths & Weaknesses
Table 127. Abaxis (Zoetis) Basic Information, Area Served and Competitors
Table 128. Abaxis (Zoetis) Major Business
Table 129. Abaxis (Zoetis) IVD and POCT Product and Services
Table 130. Abaxis (Zoetis) IVD and POCT Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 131. Abaxis (Zoetis) Recent Developments/Updates
Table 132. Abaxis (Zoetis) Competitive Strengths & Weaknesses
Table 133. Ortho Clinical Diagnostics Basic Information, Area Served and Competitors
Table 134. Ortho Clinical Diagnostics Major Business
Table 135. Ortho Clinical Diagnostics IVD and POCT Product and Services
Table 136. Ortho Clinical Diagnostics IVD and POCT Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 137. Ortho Clinical Diagnostics Recent Developments/Updates
Table 138. Ortho Clinical Diagnostics Competitive Strengths & Weaknesses
Table 139. Phamatech Basic Information, Area Served and Competitors
Table 140. Phamatech Major Business
Table 141. Phamatech IVD and POCT Product and Services
Table 142. Phamatech IVD and POCT Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 143. Phamatech Recent Developments/Updates
Table 144. Phamatech Competitive Strengths & Weaknesses
Table 145. Chembio Diagnostics Basic Information, Area Served and Competitors
Table 146. Chembio Diagnostics Major Business
Table 147. Chembio Diagnostics IVD and POCT Product and Services
Table 148. Chembio Diagnostics IVD and POCT Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 149. Chembio Diagnostics Recent Developments/Updates
Table 150. Chembio Diagnostics Competitive Strengths & Weaknesses
Table 151. Trinity Biotech Basic Information, Area Served and Competitors
Table 152. Trinity Biotech Major Business
Table 153. Trinity Biotech IVD and POCT Product and Services
Table 154. Trinity Biotech IVD and POCT Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 155. Trinity Biotech Recent Developments/Updates
Table 156. Trinity Biotech Competitive Strengths & Weaknesses
Table 157. ELITech Group Basic Information, Area Served and Competitors
Table 158. ELITech Group Major Business
Table 159. ELITech Group IVD and POCT Product and Services
Table 160. ELITech Group IVD and POCT Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 161. ELITech Group Recent Developments/Updates
Table 162. ELITech Group Competitive Strengths & Weaknesses
Table 163. Response Biomedical Basic Information, Area Served and Competitors
Table 164. Response Biomedical Major Business
Table 165. Response Biomedical IVD and POCT Product and Services
Table 166. Response Biomedical IVD and POCT Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 167. Response Biomedical Recent Developments/Updates
Table 168. Response Biomedical Competitive Strengths & Weaknesses
Table 169. Princeton BioMeditech Basic Information, Area Served and Competitors
Table 170. Princeton BioMeditech Major Business
Table 171. Princeton BioMeditech IVD and POCT Product and Services
Table 172. Princeton BioMeditech IVD and POCT Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 173. Princeton BioMeditech Recent Developments/Updates
Table 174. Alfa Wassermann Basic Information, Area Served and Competitors
Table 175. Alfa Wassermann Major Business
Table 176. Alfa Wassermann IVD and POCT Product and Services
Table 177. Alfa Wassermann IVD and POCT Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 178. IVD and POCT Raw Material
Table 179. Key Manufacturers of IVD and POCT Raw Materials
Table 180. IVD and POCT Typical Distributors
Table 181. IVD and POCT Typical Customers
LIST OF FIGURES
Figure 1. IVD and POCT Picture
Figure 2. World IVD and POCT Total Market Size: 2017 & 2021 & 2028, (USD Million)
Figure 3. World IVD and POCT Total Market Size (2017-2028) & (USD Million)
Figure 4. World IVD and POCT Market Size Market Share by Region (2017-2028)
Figure 5. United States IVD and POCT Market Size (2017-2028) & (USD Million)
Figure 6. China IVD and POCT Market Size (2017-2028) & (USD Million)
Figure 7. Europe IVD and POCT Market Size (2017-2028) & (USD Million)
Figure 8. Japan IVD and POCT Market Size (2017-2028) & (USD Million)
Figure 9. South Korea IVD and POCT Market Size (2017-2028) & (USD Million)
Figure 10. ASEAN IVD and POCT Market Size (2017-2028) & (USD Million)
Figure 11. India IVD and POCT Market Size (2017-2028) & (USD Million)
Figure 12. IVD and POCT Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. Producer Shipments of IVD and POCT by Player Revenue ($MM) and Market Share (%): 2021
Figure 15. Global Four-firm Concentration Ratios (CR4) for IVD and POCT Markets in 2021
Figure 16. Global Four-firm Concentration Ratios (CR8) for IVD and POCT Markets in 2021
Figure 17. United States VS China: IVD and POCT Market Size Market Share Comparison (2017 & 2021 & 2028)
Figure 18. World IVD and POCT Market Size by Type, (USD Million), 2017 & 2021 & 2028
Figure 19. World IVD and POCT Market Size Market Share by Type in 2021
Figure 20. POCT
Figure 21. IVD
Figure 22. World IVD and POCT Market Size Market Share by Type (2017-2028)
Figure 23. World IVD and POCT Market Size by Application, (USD Million), 2017 & 2021 & 2028
Figure 24. World IVD and POCT Market Size Market Share by Application in 2021
Figure 25. Clinics
Figure 26. Hospitals
Figure 27. Laboratory
Figure 28. Others
Figure 29. World IVD and POCT Market Size Market Share by Application (2017-2028)
Figure 30. Manufacturing Cost Structure Analysis of IVD and POCT in 2021
Figure 31. Manufacturing Process Analysis of IVD and POCT
Figure 32. IVD and POCT Industrial Chain
Figure 33. Distribution Channel Breakdown for IVD and POCT Shipments (%): 2017-2028
Figure 34. Direct Channel Pros & Cons
Figure 35. Indirect Channel Pros & Cons
Figure 36. Methodology
Figure 37. Research Process and Data Source
Figure 1. IVD and POCT Picture
Figure 2. World IVD and POCT Total Market Size: 2017 & 2021 & 2028, (USD Million)
Figure 3. World IVD and POCT Total Market Size (2017-2028) & (USD Million)
Figure 4. World IVD and POCT Market Size Market Share by Region (2017-2028)
Figure 5. United States IVD and POCT Market Size (2017-2028) & (USD Million)
Figure 6. China IVD and POCT Market Size (2017-2028) & (USD Million)
Figure 7. Europe IVD and POCT Market Size (2017-2028) & (USD Million)
Figure 8. Japan IVD and POCT Market Size (2017-2028) & (USD Million)
Figure 9. South Korea IVD and POCT Market Size (2017-2028) & (USD Million)
Figure 10. ASEAN IVD and POCT Market Size (2017-2028) & (USD Million)
Figure 11. India IVD and POCT Market Size (2017-2028) & (USD Million)
Figure 12. IVD and POCT Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. Producer Shipments of IVD and POCT by Player Revenue ($MM) and Market Share (%): 2021
Figure 15. Global Four-firm Concentration Ratios (CR4) for IVD and POCT Markets in 2021
Figure 16. Global Four-firm Concentration Ratios (CR8) for IVD and POCT Markets in 2021
Figure 17. United States VS China: IVD and POCT Market Size Market Share Comparison (2017 & 2021 & 2028)
Figure 18. World IVD and POCT Market Size by Type, (USD Million), 2017 & 2021 & 2028
Figure 19. World IVD and POCT Market Size Market Share by Type in 2021
Figure 20. POCT
Figure 21. IVD
Figure 22. World IVD and POCT Market Size Market Share by Type (2017-2028)
Figure 23. World IVD and POCT Market Size by Application, (USD Million), 2017 & 2021 & 2028
Figure 24. World IVD and POCT Market Size Market Share by Application in 2021
Figure 25. Clinics
Figure 26. Hospitals
Figure 27. Laboratory
Figure 28. Others
Figure 29. World IVD and POCT Market Size Market Share by Application (2017-2028)
Figure 30. Manufacturing Cost Structure Analysis of IVD and POCT in 2021
Figure 31. Manufacturing Process Analysis of IVD and POCT
Figure 32. IVD and POCT Industrial Chain
Figure 33. Distribution Channel Breakdown for IVD and POCT Shipments (%): 2017-2028
Figure 34. Direct Channel Pros & Cons
Figure 35. Indirect Channel Pros & Cons
Figure 36. Methodology
Figure 37. Research Process and Data Source
